Dr. Andrews is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4410 Medical Dr
Suite 360
San Antonio, TX 78229Phone+1 210-692-7157Fax+1 210-692-1999
Summary
- Dr. Charles Porter Andrews is a pulmonologist in San Antonio, TX. He received his medical degree from Southwestern Medical School. In 2000, he founded Diagnostics Research Group which in 2021 became part of IMA Clinical Research. He has been a Principal Investigator for 350+ clinical trials. He has more than 40 publications in the areas of ARDS, fungal infections, COPD, hypersensitivity pneumonitis, allergy and vaccines.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1980- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1975 - 1978
University of Texas Southwestern Medical SchoolClass of 1975
Certifications & Licensure
TX State Medical License 1975 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
- ACRPCertified Principal Investigator
Awards, Honors, & Recognition
- Fellow (FACP) American College of Chest Physicians, 1988
- Certified Principal Investigator Association of Clinical Research Professionals, 2002
- Fellow (FACP) American College of Physicians, 2002
- Join now to see all
Clinical Trials
- A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2020 Jul 28
Publications & Presentations
PubMed
- 16 citationsA phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine ...Kevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, Clemente Diaz-Perez, Charles P Andrews
Human Vaccines & Immunotherapeutics. 2022-11-30 - 6 citationsLarge-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthmaAlisha M. Smith, Robert M. Ramirez, Nathan Harper, Fabio Jimenez, Anne P. Branum
Allergy. 2021-10-22 - 5 citationsRepetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseasesAlisha M. Smith, Nathan Harper, Justin A. Meunier, Anne P. Branum, Fabio Jimenez
The Journal of Allergy and Clinical Immunology. 2021-08-01
Journal Articles
- Immune responses to a recombinant glycoprotein E Herpes Zoster vaccine in adults aged 50 and olderCunningham A, Heineman T, Lal H, Godeaux o, Chilibek R, Hwang J, McElhaney J, Vesikari T, Andrews C, et al, Journal of Infectious Disease, 2018
- Safety and Immunogenicity of 15-valent pneumococcal congugate vaccine in pneumococcal vaccine-naive adults 50 years of age and olderErmlich S, Andrews C, Folkreth S, Rupp R, Greenberg D, Vaccine, 2018
- The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitisAndrews CP, Ratner PH, Ehler BR, Brooks EG, Pollack BH, Ramirez DA, Jacobs RL, Ann Allergy Asthma Immunol
- Join now to see all
Professional Memberships
- Member
- Fellow
- Fellow
- Texas Medical AssociationMember
External Links
- Diagnostics Research Grouphttp://DXRG.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
